Symmetry Plays a Key Role in the Erasing of Patterned Surface Features

We report on how the relaxation of patterns prepared on a thin film can be controlled by manipu- lating the symmetry of the initial shape. The validity of a lubrication theory for the capillary-driven relaxation of surface profiles is verified by atomic force microscopy measurements, performed on films that were patterned using focused laser spike annealing. In particular, we observe that the shape of the surface profile at late times is entirely determined by the initial symmetry of the perturba- tion, in agreement with the theory. Moreover, in this regime the perturbation amplitude relaxes as a power-law in time, with an exponent that is also related to the initial symmetry. The results have relevance in the dynamical control of topographic perturbations for nanolithography and high density memory storage

Influence d'une faculte´ des sciences de l'administration sur les valeurs humaines de ses e´tudiants

This study indicates that schools of business influence the personal values of their students. Current management education produces individuals who have ego-centered rather than society or other-centered values. Given this framework the authors raise the question, "Do business schools produce the type of manager that is needed in the future?".Cette e´tude indique que les e´coles d'administration influencent les valeurs personnelles de leurs e´tudiants. L'e´ducation manage´riale actuelle produit des individus centre´s sur eux- me^mes pluto^t que sur des valeurs socie´tales ou sur d'autres types de valeurs. Etant donne´ cette situation, les auteurs posent la question: "Est-ce que les e´coles d'administration pro- duisent le type de gestionnaire dont nous aurons besoin dans l'avenir"

Exploitation of trophic resources by fish under stressful estuarine conditions

Despite the high complexity and variability of estuaries, these ecosystems are very productive and play an important role in fish feeding. This paper constitutes a preliminary investigation to test how fish optimize the use of the available trophic resources, by studying trophic preference variability and feeding strategies of some pelagic and demersal fish in the Gironde estuary (southwest France). Fish and their prey were collected approximately every two months from July 2003 to June 2004 in the upstream area of the saline estuary. Stomach content analyses were realized to describe the variability of fish feeding according to their size and the time of year. Intra- and interspecific food niche overlap was evaluated using Schoener's index and a cross-calculation method was used to highlight the general fish trends in predation strategy. Stomach content results showed interspecific and intraspecific variability in fish feeding, which can be explained by their different or evolutionary ecomorphology. Their diets are composed mainly of zooplankton and hyperbenthic crustaceans with temporal variations in the consumed taxa. Optimization of the available trophic resource use, a key element in estuarine resilience, is thus possible due to the temporal adaptation of this structural trophic web. However, in spite of their temporal adaptation capacity, most fish species exhibited a specialist feeding strategy. This result was not expected, especially in the high turbidity of the Gironde estuary; the loss of one of these species could affect the fish trophic web structure and hence the resilience of the system

A Note on (Meta)stable Brane Configurations in MQCD

We examine the M-theory version of SQCD which is known as MQCD. In the IIA limit, this theory appears to have a supersymmetry-breaking brane configuration which corresponds to the meta-stable state of N=1 SU(Nc) SQCD. However, the behavior at infinity of this non-supersymmetric brane construction differs from that of the supersymmetric ground state of MQCD. We interpret this to mean that it is not a meta-stable state in MQCD, but rather a state in another theory. This provides a concrete example of the fact that, while MQCD accurately describes the supersymmetric features of SCQD, it fails to reproduce its non-supersymmetric features (such as meta-stable states) not only quantitatively but also qualitatively.Comment: 30 pages, 7 figures, harvmac. v2 typo correcte

Preparation of 3-Bromo-1,2,4,5-tetrazine

In this synthetic procedure, a seven-step protocol for the preparation of monosubstituted 3-bromo-1,2,4,5-tetrazine is presented. The procedure features efficient transformations and purification methods starting from commercially readily available starting materials and affords the title compound on a gram scale with 13 % overall yield in reliable purity (>97 %). Detailed experimental procedures, supported by images and additional notes, allow the preparation of a valuable advanced building block, enabling further applications in bioconjugation, protein labelling, bio-orthogonal chemistry, heterocycle syntheses, high energy materials, and drug release, among others.

Decision criteria for selecting essential medicines and their connection to guidelines:an interpretive descriptive qualitative interview study

Background and Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be available, accessible, affordable, and the supporting evidence should be accompanied by a rating of the certainty one can place in it. Our objectives were to identify criteria and considerations that should be addressed in moving from a guideline recommendation regarding a medicine to the decision of whether to add, maintain, or remove a medicine from an essential medicines list. We also seek to explore opportunities to improve organizational processes to support evidence-based health decision-making more broadly. Methods: We conducted a qualitative study with semistructured interviews of key informant stakeholders in the development and use of guidelines and essential medicine lists (EMLs). We used an interpretive descriptive analysis approach and thematic analysis of interview transcripts in NVIVO v12. Results: We interviewed 16 key informants working at national and global levels across all WHO regions. We identified five themes: three descriptive/explanatory themes 1) EMLs and guidelines, the same, but different; 2) EMLs can drive price reductions and improve affordability and access; 3) Time lag and disconnect between guidelines and EMLs; and two prescriptive themes 4) An “evidence pipeline” could improve coordination between guidelines and EMLs; 5) Facilitating the link between the WHO Model List of Essential Medicines (WHO EML) and national EMLs could increase alignment. Conclusion: We found significant overlap and opportunities for alignment between guideline and essential medicine decision processes. This finding presents opportunities for guideline and EML developers to enhance strategies for collaboration. Future research should assess and evaluate these strategies in practice to support the shared goal of guidelines and EMLs: improvements in health.</p

Decision criteria for selecting essential medicines and their connection to guidelines:an interpretive descriptive qualitative interview study

Background and Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be available, accessible, affordable, and the supporting evidence should be accompanied by a rating of the certainty one can place in it. Our objectives were to identify criteria and considerations that should be addressed in moving from a guideline recommendation regarding a medicine to the decision of whether to add, maintain, or remove a medicine from an essential medicines list. We also seek to explore opportunities to improve organizational processes to support evidence-based health decision-making more broadly. Methods: We conducted a qualitative study with semistructured interviews of key informant stakeholders in the development and use of guidelines and essential medicine lists (EMLs). We used an interpretive descriptive analysis approach and thematic analysis of interview transcripts in NVIVO v12. Results: We interviewed 16 key informants working at national and global levels across all WHO regions. We identified five themes: three descriptive/explanatory themes 1) EMLs and guidelines, the same, but different; 2) EMLs can drive price reductions and improve affordability and access; 3) Time lag and disconnect between guidelines and EMLs; and two prescriptive themes 4) An “evidence pipeline” could improve coordination between guidelines and EMLs; 5) Facilitating the link between the WHO Model List of Essential Medicines (WHO EML) and national EMLs could increase alignment. Conclusion: We found significant overlap and opportunities for alignment between guideline and essential medicine decision processes. This finding presents opportunities for guideline and EML developers to enhance strategies for collaboration. Future research should assess and evaluate these strategies in practice to support the shared goal of guidelines and EMLs: improvements in health.</p

Decision criteria for selecting essential medicines and their connection to guidelines:an interpretive descriptive qualitative interview study

Background and Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be available, accessible, affordable, and the supporting evidence should be accompanied by a rating of the certainty one can place in it. Our objectives were to identify criteria and considerations that should be addressed in moving from a guideline recommendation regarding a medicine to the decision of whether to add, maintain, or remove a medicine from an essential medicines list. We also seek to explore opportunities to improve organizational processes to support evidence-based health decision-making more broadly. Methods: We conducted a qualitative study with semistructured interviews of key informant stakeholders in the development and use of guidelines and essential medicine lists (EMLs). We used an interpretive descriptive analysis approach and thematic analysis of interview transcripts in NVIVO v12. Results: We interviewed 16 key informants working at national and global levels across all WHO regions. We identified five themes: three descriptive/explanatory themes 1) EMLs and guidelines, the same, but different; 2) EMLs can drive price reductions and improve affordability and access; 3) Time lag and disconnect between guidelines and EMLs; and two prescriptive themes 4) An “evidence pipeline” could improve coordination between guidelines and EMLs; 5) Facilitating the link between the WHO Model List of Essential Medicines (WHO EML) and national EMLs could increase alignment. Conclusion: We found significant overlap and opportunities for alignment between guideline and essential medicine decision processes. This finding presents opportunities for guideline and EML developers to enhance strategies for collaboration. Future research should assess and evaluate these strategies in practice to support the shared goal of guidelines and EMLs: improvements in health.</p

Decision criteria for selecting essential medicines and their connection to guidelines:an interpretive descriptive qualitative interview study

Background and Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be available, accessible, affordable, and the supporting evidence should be accompanied by a rating of the certainty one can place in it. Our objectives were to identify criteria and considerations that should be addressed in moving from a guideline recommendation regarding a medicine to the decision of whether to add, maintain, or remove a medicine from an essential medicines list. We also seek to explore opportunities to improve organizational processes to support evidence-based health decision-making more broadly. Methods: We conducted a qualitative study with semistructured interviews of key informant stakeholders in the development and use of guidelines and essential medicine lists (EMLs). We used an interpretive descriptive analysis approach and thematic analysis of interview transcripts in NVIVO v12. Results: We interviewed 16 key informants working at national and global levels across all WHO regions. We identified five themes: three descriptive/explanatory themes 1) EMLs and guidelines, the same, but different; 2) EMLs can drive price reductions and improve affordability and access; 3) Time lag and disconnect between guidelines and EMLs; and two prescriptive themes 4) An “evidence pipeline” could improve coordination between guidelines and EMLs; 5) Facilitating the link between the WHO Model List of Essential Medicines (WHO EML) and national EMLs could increase alignment. Conclusion: We found significant overlap and opportunities for alignment between guideline and essential medicine decision processes. This finding presents opportunities for guideline and EML developers to enhance strategies for collaboration. Future research should assess and evaluate these strategies in practice to support the shared goal of guidelines and EMLs: improvements in health.</p

Decision criteria for selecting essential medicines and their connection to guidelines:an interpretive descriptive qualitative interview study

Background and Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be available, accessible, affordable, and the supporting evidence should be accompanied by a rating of the certainty one can place in it. Our objectives were to identify criteria and considerations that should be addressed in moving from a guideline recommendation regarding a medicine to the decision of whether to add, maintain, or remove a medicine from an essential medicines list. We also seek to explore opportunities to improve organizational processes to support evidence-based health decision-making more broadly. Methods: We conducted a qualitative study with semistructured interviews of key informant stakeholders in the development and use of guidelines and essential medicine lists (EMLs). We used an interpretive descriptive analysis approach and thematic analysis of interview transcripts in NVIVO v12. Results: We interviewed 16 key informants working at national and global levels across all WHO regions. We identified five themes: three descriptive/explanatory themes 1) EMLs and guidelines, the same, but different; 2) EMLs can drive price reductions and improve affordability and access; 3) Time lag and disconnect between guidelines and EMLs; and two prescriptive themes 4) An “evidence pipeline” could improve coordination between guidelines and EMLs; 5) Facilitating the link between the WHO Model List of Essential Medicines (WHO EML) and national EMLs could increase alignment. Conclusion: We found significant overlap and opportunities for alignment between guideline and essential medicine decision processes. This finding presents opportunities for guideline and EML developers to enhance strategies for collaboration. Future research should assess and evaluate these strategies in practice to support the shared goal of guidelines and EMLs: improvements in health.</p